Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Pre-Mkt 06-10 04:07:59 EDT

3.63

-0.10

-2.68%

High3.83	Low3.50	Vol28.30K
Open3.81	D1 Closing3.73	Amplitude8.71%
Mkt Cap30.14M	Tradable Cap20.08M	Total Shares8.30M
T/O103.22K	T/O Rate0.51%	Tradable Shares5.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":3.63,"timestamp":1781035200000,"preClose":3.73,"halted":0,"volume":28300,"delay":0,"changeRate":-0.026809651474530856,"floatShares":5531900,"shares":8302700,"eps":-1.371838,"marketStatus":"Pre-Mkt","change":-0.1,"latestTime":"06-10 04:07:59 EDT","open":3.81,"high":3.825,"low":3.5,"amount":103219,"amplitude":0.087131,"askPrice":5.8,"askSize":200,"bidPrice":1.46,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.371838,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1781098200000},"marketStatusCode":1,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":3.63,"postHourTrading":{"tag":"盘后","latestPrice":3.63,"preClose":3.63,"latestTime":"16:10 EDT","volume":6,"amount":21.78,"timestamp":1781035804672,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7111982324087213,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX","defaultTab":"news","newsList":[{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AUTL","LU1829250122.USD","BK4532","BDRX","NOK","SQNS","LU1093756325.SGD","BP","BK4141","BK4599","BK4077","GSK.UK","TRVG","LU1162221912.USD","MREO","LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","NVOX","BK4505","GSK","BK4201","LU0300736492.USD","AMRN","IE00BFXG1179.USD","BK4007","IE00BKVL7J92.USD","LNOK","LU0154236417.USD","NGG","LU0162691827.USD","GRFS","LU0300736062.USD","LU0072461881.USD","LU0006061336.USD","LU0320765646.SGD","SNY","BPH","BK4020","BK4208","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","NVOH","EVAX","NCNA","CLLS","BK4139","BK4547","BK4588","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640884841","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640884841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640884841?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:10","pubTimestamp":1780499458,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were declining late Wednesday morning, falling 0.58% to 1,880.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and petroleum refiner Equinor , which rose 2.1% and 1.3%, respectively. They were followed by oil and gas company Eni  and biopharmaceutical company argenx , which were up 1% and 0.5%, respectively.The decliners from continental Europe were led by internet ad firm Criteo  and biopharmaceutical company Cellectis , which fell 7% and 4.7%, respectively. They were followed by biotech firm Evaxion  and software company SAP , which were down 4.6% and 4.5%, respectively.The gainers from the UK were led by Mereo BioPharma Group , which advanced 5.6%. It was followed by pharmaceutical company Silence Therapeutics  and medical device maker Smith & Nephew , which increased 4.8% and 2%, respectively.The decliners from the UK and Ireland were led by com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AFG","AUTL","NOK","DAVA","WPP","CRTO","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4134","IE0002141913.USD","SLN","LU0889565916.HKD","MREO","LU0109394709.USD","BK4505","BK4207","EQNR","SNN","BK4201","LNOK","IE0034235188.USD","EPV","E","LU2324357040.USD","SAP","IE00BFMHRM44.USD","BK4521","BCS","BK4009","DAVA.AU","WPP.AU","LU0320765992.SGD","LU1983260115.SGD","ARGX","BK4020","LU0084288595.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IEUR","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","EVAX","NCNA","IE00B4R5TH58.HKD","CLLS","BK4139","BK4547","BK4588","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640681299","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640681299","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640681299?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:11","pubTimestamp":1780326713,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the trading week lower late Monday morning, declining 0.2% to 1,867.7 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP  and petroleum refiner Equinor , which advanced 7.2% and 5.6% respectively. They were followed by accommodations booking site trivago  and telecommunications company Nokia , which increased 5.2% and 4.8% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which dropped 7.2% and 4.8% respectively. They were followed by biotech firm BioNTech  and lender Banco Bilbao Vizcaya Argentaria , which fell 4.3% and 2.5% respectively.The gainers from the UK were led by software company Endava  and oil and gas company BP , which rose 5.9% and 3.6% respectively. They were followed by oil and gas company Shell  and communications company WPP , which were up 2.2% and 0.9% resp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PXE","EQNR","FTXN","ERX","BK4505","BK4077","BPH","IEUR","MREO","VDE","WPP","SLN","BBVA","NCNA","AFG","LU0278409577.USD","DAVA","LU0300736492.USD","SQNS","WPP.AU","DBE","BP","DAVA.AU","DRIP","XES","LNOK","BK4141","BNTX","LU1162221912.USD","DBC","EVAX","WTIU","IXC","PXJ","LU0648005311.SGD","SHEH","BK4009","TRVG","IEO","DIG","SHEL","SAP","AKTX","DRLL","GUSH","NOK","USE","EPV","LU0084288595.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636072182","title":"European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072182","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072182?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:11","pubTimestamp":1779117088,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Monday morning, rising 0.88% to 1,825.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and healthcare tech company Royal Philips , which rose 4.6% and 2.9% respectively. They were followed by internet advertising firm Criteo  and biopharmaceutical company Grifols , which were up 2.8% each.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and biotech firm BioNTech , which dropped 3.2% and 2% respectively. They were followed by telecommunications company Nokia  and pharmaceutical company Ascendis Pharma , which were down 1.9% and 0.9% respectively.The gainers from the UK were led by biotech companies Autolus Therapeutics  and Trinity Biotech , which climbed 16% and 6.2% respectively. They were followed by communications company WPP  and educational publisher Pearson , which advanced 4.8% and 4.7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NOK","IE00BFMHRM44.USD","IE00BMPRXN33.USD","BK4535","AUTL","BK4117","ASND","IEUR","LNOK","BNTX","NCNA","TRIB","BK4020","PHG","CRTO","BK4548","DBVT","BK4111","BK4009","BK4505","WPP","WPP.AU","LU0889565916.HKD","BK4204","PSO","AMRN","BDRX","BK4107","BK4568","BK4551","BK4585","BK4588","LU0320765992.SGD","BK4082","LU0109394709.USD","EPV","AFG","BK4547","GRFS","MREO","IE00BMPRXR70.SGD","BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634091212","title":"Evaxion plans EVX-04 AML vaccine clinical trial application in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634091212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634091212?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592694,"startTime":"0","endTime":"0","summary":"Evaxion flagged new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine candidate for acute myeloid leukemia, scheduled for presentation at European Hematology Association Congress 2026.Results have not yet been presented; poster disclosure set for June 13, 2026, in Stockholm.Update is expected to outline functional characterization supporting EVX-04’s development rationale, positioning program for move toward first clinical testing.Clinical trial application planned for second half of 2026, marking next major value inflection for asset.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL29Tbz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634357217","title":"Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2634357217","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634357217?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:30","pubTimestamp":1778592600,"startTime":"0","endTime":"0","summary":"Data will reflect the functional characterization of EVX-04Poster presentation on June 13, 2026 COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293006/0/en/Evaxion-to-present-new-data-for-EVX-04-an-off-the-shelf-therapeutic-vaccine-for-acute-myeloid-leukemia-at-the-EHA-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4587","BK4139","CHAT","ARTY","BK4551","BK4585","AIPO","AIYY","BK4543","AI","BK4023","AGIX","EVX","EVAX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634007804","title":"Evaxion Biotech (EVAX) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2634007804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634007804?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:38","pubTimestamp":1778495918,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Evaxion Biotech, with a price target of $16.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evaxion-biotech-evax-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","XBI","BK4581","BK4585","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634427329","title":"Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634427329?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:09","pubTimestamp":1778458186,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S Adr (($EVAX)) has held its Q1 earnings call. Read on for the main highlights of the call. Evaxion Biotech’s latest earnings cal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-signals-strong-rd-momentum-amid-cash-constraints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-signals-strong-rd-momentum-amid-cash-constraints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","EVAX","BK4139","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467257","title":"Michael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467257","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467257?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:15","pubTimestamp":1778274921,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Michael Okunewitch has maintained their bullish stance on EVAX stock, giving a Buy rating today. Michael Okunewitch has given h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/michael-okunewitch-initiates-buy-on-evaxion-citing-strong-clinical-data-ai-driven-vaccine-platform-and-cash-runway-to-2h-2027-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/michael-okunewitch-initiates-buy-on-evaxion-citing-strong-clinical-data-ai-driven-vaccine-platform-and-cash-runway-to-2h-2027-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","ARTY","AIPO","BK4139","EVAX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634029465","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2634029465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634029465?lang=en_us&edition=fundamental","pubTime":"2026-05-09 01:10","pubTimestamp":1778260212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evaxion Biotech (EVAX), Zura Bio (ZURA) and Argenx S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-157?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-157?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","LU0029874061.USD","BK4112","BK4588","XBI","BLSX","ARGX","BK4585","LABU","ZURA","LU0128526141.USD","BK4581","BK4137","BK4139","BLSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633502674","title":"European Equities Traded in the US as American Depositary Receipts Rise Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2633502674","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633502674?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:10","pubTimestamp":1778253004,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.78% to 1,826.25 on the S&P Europe Select ADR Index, which is up 1.3% for the week so far.From continental Europe, the gainers were led by telecommunications company Nokia  and biotech firm Evaxion , which rose 4.7% and 4.4% respectively. They were followed by oil and gas company Eni  and lender Banco Bilbao Vizcaya Argentaria , which increased 2.6% and 2.5% respectively.The decliners from continental Europe were led by software firm SAP  and semiconductor firm Sequans Communications , which fell 1.6% and 1.2% respectively. They were followed by biopharmaceutical company DBV Technologies  and internet browser company Opera , which were off 1% and 0.9% respectively.The gainers from the UK were led by Lloyds Banking Group , which rose 3%. It was followed by telecommunications operator Vodafone Group  and InterContinental Hotels Group , which were up 2.7% and 2.6% respectively.The d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","BK4585","IE00BMPRXN33.USD","E","VOD","EPV","BK4111","LNOK","BK4139","DAVA.AU","OPRA","BK4532","PSO","BK4142","BK4521","BK4134","BK4117","BK4547","BBVA","AFG","BK4613","DAVA","BK4023","SAP","EVAX","LU0648005311.SGD","BK4132","NOK","BK4204","BK4020","BK4082","BK4528","BDRX","BK4588","BK4141","IE00BMPRXR70.SGD","DBVT","LU0084288595.USD","LYG","BK4201","SNN","BK4107","IEUR","IHG","SQNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128229","title":"Evaxion A/S reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128229","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633128229?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:33","pubTimestamp":1778160783,"startTime":"0","endTime":"0","summary":"Evaxion A/S reports results for the quarter ended March 31 - Earnings SummaryEvaxion A/S EVAX.OQ reported a quarterly adjusted loss of 50 cents per share for the quarter ended March 31, identical to t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K1QR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149030","title":"Denmark's Evaxion Q1 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149030?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:43","pubTimestamp":1778154186,"startTime":"0","endTime":"0","summary":"Denmark's Evaxion Q1 net loss widensOverviewDenmark vaccine developer reported Q1 net loss widened yr/yrQ1 net loss increased due to lower financial income from derivative remeasurementCompany maintai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K0OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149869","title":"BRIEF-Evaxion Q1 Basic EPS USD -0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149869","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149869?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153447,"startTime":"0","endTime":"0","summary":"BRIEF-Evaxion Q1 Basic EPS USD -0.01\n\n\nMay 07 (Reuters) - Evaxion Q1 net income USD -3.629 million.\n\nQ1 pretax profit USD -3.845 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633514677","title":"Evaxion Q1 Pretax Profit USD -3.845 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633514677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633514677?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633047146","title":"Evaxion Q1 Net Income USD -3.629 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633047146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633047146?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX284870:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146011","title":"Evaxion Announces Business Update and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146011?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA2JG9RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149316","title":"Press Release: Evaxion announces business update and first quarter 2026 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149316?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153400,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, May 7, 2026 - Evaxion A/S  , a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology platform, provides business update and announces first quarter 2026 financial results.Evaxion has had a good start to the year executing on our plans and achieving our first milestone for 2026 as expected. Highlights include:. -- New data demonstrating an 86% vaccine target recognition by. AI-Immunology in personalized cancer vaccine EVX-01 is a further. scientific validation of the platform's precision in driving immune. response. This marked our first milestone for the year. -- Another new set of data confirming the platform's unique scalability in. -- Successful completion of the one-year extension of our phase 2 trial with. EVX-01 paving the way for presentation of three-year clinical data in the. EVX-01 is our most advanced asset. Developed with AI-Immunology, i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","ARTY","BK4585","AIPO","AGIX","BK4543","BK4099","CHAT","BK4528","TM","03160","BK4139","EVAX","BK4587","AIYY","BK4551","BK4555","BK4588","BK4023","AI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633945947","title":"Evaxion A/S  expected to post a loss of 30 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633945947","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633945947?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:20","pubTimestamp":1777987206,"startTime":"0","endTime":"0","summary":"Evaxion A/S  expected to post a loss of30cents a share - Earnings Preview Evaxion A/S EVAX.OQ EVAX.O is expected to  show no change in quarterly revenue when it reports  results on May 7 for the perio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1SA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632584939","title":"Evaxion to report Q1 results, host business update call","url":"https://stock-news.laohu8.com/highlight/detail?id=2632584939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632584939?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:01","pubTimestamp":1777896088,"startTime":"0","endTime":"0","summary":"Evaxion schedules first-quarter 2026 financial results release for May 7, 2026, ahead of Nasdaq CM open.Business update presentation set for May 7 at 14:30 CET/08:30 EST via conference call and webcast, with Q&A.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLsnFbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","LU0314104364.USD","EVAX","BK4588","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BKPKM429.USD","NDAQ","LU2095319765.USD","SG9999014021.USD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxion.ai","stockEarnings":[{"period":"1week","weight":-0.032},{"period":"1month","weight":-0.1636},{"period":"3month","weight":-0.062},{"period":"6month","weight":-0.4372},{"period":"1year","weight":0.206},{"period":"ytd","weight":-0.239}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.312391},{"month":2,"riseRate":0,"avgChangeRate":-0.075072},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.067423},{"month":4,"riseRate":0.666667,"avgChangeRate":0.093874},{"month":5,"riseRate":0.333333,"avgChangeRate":0.041103},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.052762},{"month":7,"riseRate":0.4,"avgChangeRate":0.060856},{"month":8,"riseRate":0.6,"avgChangeRate":-0.04913},{"month":9,"riseRate":1,"avgChangeRate":0.19717},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S","securityTypeName":"DR","adrRate":"1:50"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction